Tirzepatide represents a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://rajanlhbz524649.blogpixi.com/40897394/tirzepatide-a-new-frontier-in-diabetes-treatment